JBT Company Report

JBT Marrel reported strong Q3 2025 results, with total revenue of approximately $1,000,000,000, a 7% sequential increase, and adjusted EPS of $1.94. This performance significantly exceeded expectations due to excellent manufacturing productivity, a favorable equipment mix, and accelerated synergy savings.
The company raised its full-year 2025 guidance, now expecting revenue between $3,760,000,000 and $3,790,000,000, adjusted EBITDA margin of 15.5% to 16%, and adjusted EPS of $6.1 to $6.4.
Demand remained healthy, with combined orders of $946,000,000, up 7% from the prior year, and a quarter-end backlog of $1,300,000,000. Robust demand was noted in the poultry industry, pet food, and pharmaceutical sectors.
Significant progress was made on integration, with $14,000,000 in year-over-year synergy savings realized in Q3, and the full-year in-year synergy savings target increased to $40,000,000 to $45,000,000. Financial leverage decreased to 3.1 times by the end of Q3, with expectations to be below three times by year-end.
JBT Marrel plans to introduce new segment reporting in 2025, categorizing operations into "Protein Solutions" and "Prepared Food and Beverage Solutions".

Nov 4, 2025, 3:00 PM

JBT Marel Exceeds Q3 2025 Expectations and Raises Full-Year Guidance

JBT

Earnings

Guidance Update

M&A

JBT Marel significantly exceeded revenue and earnings expectations for the third quarter of 2025, reporting total revenue of approximately $1 billion and adjusted EPS of $1.94.
The company raised its full-year 2025 guidance, now expecting revenue between $3.76-$3.79 billion and adjusted EPS of $6.10-$6.40.
Combined JBT/Marel orders increased 7% from the prior year period to $946 million, and the company ended the quarter with a backlog of $1.3 billion.
JBT Marel made significant progress on deleveraging its balance sheet, with financial leverage decreasing to 3.1 times by the end of Q3, and expects to be below three times by year-end.
The company plans to introduce new segment reporting in the fourth quarter of 2025, with segments named Protein Solutions and Prepared Food and Beverage Solutions, and will recast historical financials for comparability.

Nov 4, 2025, 3:00 PM

JBT Marel Announces Solid Q3 2025 Results and Raises Full-Year Guidance

JBT

Earnings

Guidance Update

M&A

JBT Marel delivered strong Q3 2025 results, with revenue of $1,001 million, Adjusted EBITDA of $171 million, and Adjusted EPS of $1.94, all exceeding expectations.
The company generated $88 million in quarterly cash from operating activities and $163 million in year-to-date free cash flow.
JBT Marel raised its full-year 2025 guidance, projecting revenue between $3,760 million and $3,790 million and Adjusted EPS between $6.10 and $6.40.
The company further de-levered its balance sheet, achieving a bank leverage ratio of 2.7x and a net debt to trailing twelve months pro forma adjusted EBITDA of 3.1x, while also realizing $14 million in year-over-year synergy savings in Q3 2025.